Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine 0.05% eye drops versus artificial tears for dry eye after cataract surgery
IRCT20211227053548N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, single-blind trial of cyclosporine and artificial tears in dry eye syndrome (DED) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Dry eye. Started Jan 2022; status: completed.
02
Drugs
cyclosporineartificial tears
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on IRCT20211227053548N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211227053548N1.